Status:
UNKNOWN
Early Individualized-Exercise Based Cardiac Rehabilitation Programs in Patients With Acute Myocardial Infarction
Lead Sponsor:
RenJi Hospital
Conditions:
Acute Myocardial Infarction
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
Acute myocardial infarction (AMI) is a life-threatening condition and a cause of functional disability. After reperfusion therapies and pharmacological strategies, patients suffered great pain physica...
Detailed Description
Acute myocardial infarction (AMI) is a life-threatening condition and a cause of functional disability, although reperfusion therapies and pharmacological strategies have been developed dramatically. ...
Eligibility Criteria
Inclusion
- Inclusion criteria
- Acute myocardial infarction (AMI) within 1 months prior to recruitment.
- Complete revascularization.
- Man or non- pregnant women aged from 18 to 80 years.
- Exclusion criteria
- Uncontrolled hypertension (systolic blood pressure/diastolic blood pressure \>160/100 mmHg)，or symptomatic hypotension.
- Significant resting electrocardiogram abnormalities (left bundle branch block, non-specific intraventricular conduction delay, left ventricular hypertrophy, resting ST-segment depression), life-threatening cardiac arrhythmias.
- Acute myocarditis, pericarditis or acute systemic illness.
- Those who are assessed by the doctor as high-risk \[12\].
- Pacemaker or implantable cardioverter defibrillator.
- Any contraindication to exercise testing or exercise training or inability to complete a CPET.
- Life-threatening diseases with limited life expectancy \<3 year.
- Uncontrolled unstable angina pectoris.
- Significant valvular disease (mitral stenosis, moderate to severe mitral insufficiency, aortic stenosis, or aortic insufficiency, severe mitral / aortic regurgitation).
- Severe mental or cognitive impairment.
- Inability to follow the procedures of the study.
Exclusion
Key Trial Info
Start Date :
February 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 1 2023
Estimated Enrollment :
160 Patients enrolled
Trial Details
Trial ID
NCT04511182
Start Date
February 1 2021
End Date
February 1 2023
Last Update
February 5 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
RenJi Hospital, Shanghai JiaoTong University, School of Medicine
Shanghai, Shanghai Municipality, China, 200127